Statistics

Total Visits

Views
Cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: analysis by age group71

Select a period of time:

Number of views in the range

Views
Cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: analysis by age group26

Views

Views
September 202516
October 20250
November 20252
December 20251
January 20263
February 20260
March 20264
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States18
Argentina2
Brazil1
Congo1
Chile1
Colombia1
Ireland1
Venezuela1
 

Top cities views

Views
Dallas15
Ashburn1
Bogotá1
Brazzaville1
Catanduva1
Ciudad Bolívar1
Dublin1
San Jose1
San Juan1
San Vicente1